Cargando…

Should we apply sorafenib in hepatocellular carcinoma patients with microvascular invasion after curative hepatectomy?

OBJECTIVE: Microvascular invasion (MVI) has been proved to be an independent risk factor for the recurrence of HCC. If promptly treated, the recurrence rate can be reduced and the total survival time can be prolonged. The aim of this study is to analyze the effect of sorafenib on the clinical outcom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yun, Zhang, Zeyu, Zhou, Yufan, Yang, Jiajin, Hu, Kuan, Wang, Zhiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334782/ https://www.ncbi.nlm.nih.gov/pubmed/30666133 http://dx.doi.org/10.2147/OTT.S187357

Ejemplares similares

Severe polycystic liver diseases: hepatectomy or waiting for liver transplantation?: Two case reports
por: Zhang, Zeyu, et al.
Publicado: (2019)

Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy
por: Dai, Mu-Gen, et al.
Publicado: (2023)

Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy
por: Wei, Meng-Chao, et al.
Publicado: (2022)

HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p
por: Zhou, Yufan, et al.
Publicado: (2020)

Applying of pretreatment extent of disease system in patients with hepatocellular carcinoma after curative partial hepatectomy
por: Qiao, Guoliang, et al.
Publicado: (2016)

The prognosis of hepatocellular carcinoma after curative hepatectomy in young patients
por: Ha, Sang Yun, et al.
Publicado: (2015)

Perineural invasion as a prognostic factor for intrahepatic cholangiocarcinoma after curative resection and a potential indication for postoperative chemotherapy: a retrospective cohort study
por: Zhang, Zeyu, et al.
Publicado: (2020)

Comment on “Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Qian, Xinye
Publicado: (2023)

Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
por: Zhuang, Lei, et al.
Publicado: (2017)

Response to: “Comment on Hepatectomy Versus Sorafenib in Advanced Nonmetastatic Hepatocellular Carcinoma”
por: Famularo, Simone, et al.
Publicado: (2023)

The Prognostic Role of Mitotic Index in Hepatocellular Carcinoma Patients after Curative Hepatectomy
por: Ha, Sang Yun, et al.
Publicado: (2016)

Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria
por: Hou, Yi-Fu, et al.
Publicado: (2015)

Metadherin Is a Prognostic Predictor of Hepatocellular Carcinoma after Curative Hepatectomy
por: Ahn, Soomin, et al.
Publicado: (2013)

Individual and joint influence of cytokeratin 19 and microvascular invasion on the prognosis of patients with hepatocellular carcinoma after hepatectomy
por: Qin, Shang-Dong, et al.
Publicado: (2022)

A Combination of Sorafenib, an Immune Checkpoint Inhibitor, TACE and Stereotactic Body Radiation Therapy versus Sorafenib and TACE in Advanced Hepatocellular Carcinoma Accompanied by Portal Vein Tumor Thrombus
por: Zhang, Zeyu, et al.
Publicado: (2022)

Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy
por: Guo, Zhe, et al.
Publicado: (2015)

An accurate prognostic staging system for hepatocellular carcinoma patients after curative hepatectomy
por: TOKUMITSU, YUKIO, et al.
Publicado: (2014)

Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy
por: Wang, Yan-Yan, et al.
Publicado: (2014)

Model to Predict Overall Survival in Patients With Hepatocellular Carcinoma After Curative Hepatectomy
por: Zhang, Li-xiang, et al.
Publicado: (2021)

Simple parameters predicting extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma
por: Yoon, Jae Hyun, et al.
Publicado: (2021)

Combination of Sorafenib, Camrelizumab, Transcatheter Arterial Chemoembolization, and Stereotactic Body Radiation Therapy as a Novel Downstaging Strategy in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Case Series Study
por: Huang, Yun, et al.
Publicado: (2021)

The transcatheter arterial chemoembolization combined with targeted nanoparticle delivering sorafenib system for the treatment of microvascular invasion of hepatocellular carcinoma
por: Su, Dongna
Publicado: (2021)

Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection
por: Zhang, Zeyu, et al.
Publicado: (2020)

Nomogram For Preoperative Prediction Of Microvascular Invasion Risk In Hepatocellular Carcinoma
por: Deng, Guangtong, et al.
Publicado: (2019)

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy
por: Liang, Bin-Yong, et al.
Publicado: (2022)

Prognostic Nomogram for Sorafenib Benefit in Hepatitis B Virus-Related Hepatocellular Carcinoma After Partial Hepatectomy
por: Dong, Wei, et al.
Publicado: (2021)

Glutamine synthetase-negative hepatocellular carcinoma has better prognosis and response to sorafenib treatment after hepatectomy
por: Shao, Mingyang, et al.
Publicado: (2023)

A Nomogram Predicting Microvascular Invasion Risk in BCLC 0/A Hepatocellular Carcinoma after Curative Resection
por: Gao, Shuai-Xiang, et al.
Publicado: (2019)

Novel Prognostic Nomograms for Predicting Early and Late Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy
por: Xu, Wei, et al.
Publicado: (2020)

Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
por: Chen, Jen-Lung, et al.
Publicado: (2023)

The effectiveness of TDF versus ETV on incidence of HCC in CHB patients: a meta analysis
por: Zhang, Zeyu, et al.
Publicado: (2019)

Post-hepatectomy liver failure: Should we consider venous outflow?
por: Lhuaire, Martin, et al.
Publicado: (2015)

Efficacy of Lipid Nanoparticle-Loaded Sorafenib Combined with Hepatic Artery Chemoembolization in the Treatment of Primary Hepatocellular Carcinoma Complicated with Microvascular Invasion
por: Feng, Wendong, et al.
Publicado: (2022)

Indication of Liver Transplantation for Hepatocellular Carcinoma Should Be Reconsidered in Case of Microvascular Invasion and Multilocular Tumor Occurrence
por: Gundlach, Jan-Paul, et al.
Publicado: (2021)

Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy
por: Liao, Rui, et al.
Publicado: (2018)

Histological architectural classification determines recurrence pattern and prognosis after curative hepatectomy in patients with hepatocellular carcinoma
por: Okabe, Hirohisa, et al.
Publicado: (2018)

Prognostic Significance of Elevated Preoperative Serum CA125 Levels After Curative Hepatectomy for Hepatocellular Carcinoma
por: Huang, Yao, et al.
Publicado: (2020)

Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy
por: Wu, YiFeng, et al.
Publicado: (2021)

Impact of preoperative TACE on incidences of microvascular invasion and long‐term post‐hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis
por: Yang, Yun, et al.
Publicado: (2021)

Is laparoscopic hepatectomy superior to open hepatectomy for hepatocellular carcinoma?
por: Zhong, Jian-Hong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_93v1all1cppbek6c3lhm6j92k4